Comparison of bisoprolol fumarate and lyophilized recombinant human brain natriuretic peptide in treating patients with coronary heart disease underwent PCI

Zhang Yanan; Nie Yuanyuan

doi:10.11986/j.issn.1673-873X.2023.04.005

Home>Articles>Comparison of bisoprolol fumarate and lyophilized recombinant human brain natriuretic peptide in treating patients with coronary heart disease underwent PCI

DOI: 10.11986/j.issn.1673-873X.2023.04.005

Comparison of bisoprolol fumarate and lyophilized recombinant human brain natriuretic peptide in treating patients with coronary heart disease underwent PCI

Zhang Yanan

Nie Yuanyuan

Keywords：Coronary heart diseaseEarly cardiac rehabilitation trainingLyophilized recombinant human brain natriuretic peptide

Publication Date：2023-04-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 21-24 )

Health Medicine Research and Practice

ISTIC

ISSN：1673-873X

Year, Vol.(Issue)：2023,20(4)